基于TRIDENT发现改进晚期糖尿病肾病组织学分类
研究利用TRIDENT多中心前瞻性观察队列(176例因临床指征行肾活检的糖尿病患者),对光镜特征评分后行无监督k-means聚类,提出RPS-TRIDENT改良分类(RPS-TM)。RPS-TM新增以脏层上皮增生定义的高危Class 5,可更清晰区分风险组并改善短期预测,外部队列101例用于验证。
要点
- RPS-TM新增脏层上皮增生定义的Class 5,肾脏结局进展最快
- RPS-TM较RPS分类风险分层更清晰,1年与2年预测小幅提升
- 新分类在决策曲线分析中净获益更高,可用于风险分层与试验设计
核心结论
- RPS-TM分类通过识别以脏层上皮增生为特征、临床病程侵袭性的形态学亚组,增强了糖尿病肾病的预后判断。
- 该框架提供更精确的风险分层,或可指导糖尿病肾病的靶向管理与试验设计。
研究设计与样本
- TRIDENT为多中心、前瞻性观察队列,纳入176例因临床指征行肾活检的糖尿病患者。
- 对光镜特征评分后行无监督k-means聚类,衍生RPS-TRIDENT改良分类(RPS-TM)。
- 采用Kaplan-Meier曲线与Cox比例风险模型评估RPS-TM类别与肾脏结局的关联,并以决策曲线分析评估临床效用。
- 外部验证队列101例。
主要发现
- RPS分类预后区分能力有限,Class 3与Class 4间生存差异无统计学意义。
- RPS-TM新增由脏层上皮增生定义的高危Class 5,风险组分离更清晰。
- RPS-TM在1年预测的曲线下面积为0.68 vs. 0.65,2年为0.75 vs. 0.71,决策曲线分析净获益更高。
- RPS-TM Class 5进展至肾衰竭最快。
关键数值与推荐
- 肾脏结局定义为死亡、启动透析或估算肾小球滤过率下降40%及以上。
- RPS-TM Class 5由脏层上皮增生定义,为新增高危类别。
- 预测改善:1年AUC 0.68 vs. 0.65,2年AUC 0.75 vs. 0.71。
临床怎么用
- 在糖尿病肾病病理评估中可关注脏层上皮增生,用于识别高危Class 5患者。
- 对Class 5患者可考虑更密切随访与更积极的风险管理。
- RPS-TM框架可用于糖尿病肾病临床试验的风险分层与设计。
局限性
- 原文未报告TRIDENT与外部验证队列的具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Diabetic nephropathy (DN) remains the leading cause of kidney failure worldwide. Histopathologic assessment is the diagnostic standard, and the Renal Pathology Society (RPS) classification system is widely used in clinical practice and research. However, its prognostic performance is limited, particularly in advanced disease. METHODS: To examine this, we used TRIDENT, a multicenter, prospective observational cohort of patients with diabetes undergoing clinically indicated kidney biopsy (176 individuals). Light microscopy features were scored and analyzed by unsupervised k-means clustering to derive the RPS-TRIDENT modification (RPS-TM) classification. Associations between RPS-TM classes and kidney outcomes (death, dialysis initiation, or 40% or more decline in estimated glomerular filtration rate), were evaluated with Kaplan-Meier curves and Cox proportional hazards models. Clinical utility was assessed by decision-curve analysis. An external cohort of 101 individuals was used for validation. RESULTS: The RPS classification showed only modest prognostic discrimination, with no significant survival difference between classes 3 and 4. The RPS-TM classification introduced an additional high-risk category (Class 5) defined by visceral epithelial hyperplasia, which more clearly separated risk groups, modestly improved prediction at one year (area under the curve 0.68 vs. 0.65) and two years (0.75 vs. 0.71), and demonstrated higher net benefit in decision curve analysis. RPS-TM Class 5 had the most rapid progression to kidney failure. CONCLUSIONS: The RPS-TM classification enhances prognostication in DN by identifying a morphologic subgroup characterized by visceral epithelial hyperplasia with aggressive clinical course. This framework offers more precise risk stratification and could guide targeted management and trial design in DN.
引用
- Mohandes S, Nast CC, Mottl A, et al. Improving the histologic classification of advanced diabetic nephropathy based on the Transformative Research in Diabetic Nephropathy (TRIDENT) findings. Kidney Int. 2026. PMID: 42648400. doi:10.1016/j.kint.2026.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。